Sort
261,768 grants matching “gene therapy”
Harnessing the power of experimental genetic crosses and systems genetics to probe drug resistance in malaria
$2,408,349Michael T Ferdig · University Of Notre Dame · P01 · FY2017 · AI
Scientific innovation for personalized severe asthma management
$2,408,164Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2025 · HL
UCLA Center for AIDS Research (CFAR)
$2,407,486Jerome A. Zack · University Of California Los Angeles · P30 · FY2015 · AI
UCLA Center for AIDS Research (CFAR)
$2,407,486Jerome A. Zack · University Of California Los Angeles · P30 · FY2017 · AI
Alzheimer's Disease Research Center at Columbia University
$2,406,284Scott A Small · Columbia University Health Sciences · P50 · FY2014 · AG
Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms
$2,405,695Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Scientific innovation for personalized severe asthma management
$2,405,551Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2023 · HL
Molecular Mechanisms Regulating Calcium Flux In Salivary Glands
$2,405,513Indu S. Ambudkar · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE
Coordinating Center for the NHLBI Catalyze Program
$2,405,399Diana M Severynse-Stevens · Research Triangle Institute · OT2 · FY2022 · HL
"REAL Answers" (Registry Expansion Analyses to Learn)
$2,405,068Jeffrey Avins Glassberg · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · HL
Novel Treatment for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
$2,405,066Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Novel Treatment for Hermansky-Pudlak Syndrome Pulmonary Fibrosis
$2,405,066Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Structural Biology of Genome Maintenance and DNA repair
$2,404,933Scott Williams · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
THE THERAPY OF AML
$2,404,845Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Identification and characterization of the CD31-ApoE-mCRP pathway for Alzheimer's disease in humans.
$2,404,559Wei Qiao Qiu · Boston University Medical Campus · RF1 · FY2023 · AG
Bronchiectasis and chronic airway infection
$2,404,445Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Targeted Therapies in Melanoma
$2,404,014Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.
$2,403,712Todd C. Skaar · Indiana University Indianapolis · U01 · FY2019 · HG
Gene Therapy for Cystic Fibrosis
$2,403,656Ronald G Crystal · Weill Medical Coll Of Cornell Univ · P01 · FY2008 · HL
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
$2,403,307Paul Wesley Noble · Cedars-Sinai Medical Center · P01 · FY2018 · HL
Altered Mechanotransduction as a Therapeutic Target for Thoracic Aortic Aneurysm
$2,403,188Daniel B Rifkin · New York University School Of Medicine · P01 · FY2019 · HL
SPORE in Ovarian Cancer
$2,402,856Ie-Ming Shih · Johns Hopkins University · P50 · FY2025 · CA
Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces
$2,402,665Robert A Britton · Baylor College Of Medicine · U19 · FY2022 · AI
Functional consequences of stem and progenitor cell heterogeneity
$2,402,543David T Scadden · Massachusetts General Hospital · P01 · FY2020 · HL
Functional consequences of stem and progenitor cell heterogeneity
$2,402,543David T Scadden · Massachusetts General Hospital · P01 · FY2021 · HL